Press Releases Video Library Careers

About CG Oncology

Executive Leadership Contact Board of Directors Contact
Our Science

Unmet Need in Bladder Cancer Video Library Mechanism of Action Video Library
Congress Hub
Clinical Pipeline

Expanded Patient Access
Investor Relations

Overview

News & Events
- Press Releases - Events & Conferences

Financial Information
- SEC Filings - Quarterly Results - Annual Reports

Stock Information
- Stock Quote & Chart - Historic Price Lookup - Analyst Coverage

Corporate Governance
- Documents & Charters - Committee Composition

IR Resources
- Investor FAQs - Email Alerts - Contact IR
News & Media

Press Releases Media Resources In the News Media Resources

Press Releases Video Library Careers

NATURE MEDICINE

by admin | Nov 11, 2024 | in-the-news

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Search

Recent Posts

CG Oncology Reports…
ASCO GU 2026 – BOND-003 Cohort C Poster
ASCO GU 2026 – BOND-003 Cohort P Poster
ASCO GU 2026 – CORE-008 Cohort A Poster
ASCO GU 2026 – CRETO-EAP Poster

Recent Comments

No comments to show.

Home

About CG Oncology
Executive Leadership
Board of Directors

Our Science
Unmet Need in NMIBC
Mechanism of Action
Video Library

Clinical Pipeline
Expanded Patient Access

Investor Relations
Overview
News & Events
Financial Information
Stock Information
Corporate Governance
IR Resources

News & Media
Press Releases
In the News
Media Resources

General Inquiries
information@cgoncology.com

Medical Affairs
medicalaffairs@cgoncology.com

Media
mediarelations@cgoncology.com

Partners
bd@cgoncology.com

Investors
ir@cgoncology.com

Terms of Service

Copyright All Rights Reserved CG Oncology | © 2026

US-UNBR-1243-v1 11/2025